3 weeks Regeneron Pharmaceuticals Beats On Libtayo’s Back, Unveils Dividend Investor's Business Daily

Regeneron stock jumped Tuesday after the biotech giant topped Wall Street’s December-quarter calls on the back of its cancer drug Libtayo.
The post Regeneron Pharmaceuticals Beats On Libtayo's Back, Unveils Dividend appeared first on Investor&#039…